Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionVeracity Capital LLC
Latest Disclosed Ownership4,756 shares
Latest Disclosed Value $ 726,502
Veracity Capital LLC reports 26.29% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 9, 2026 - Veracity Capital LLC filed a 13F-HR form disclosing ownership of 4,756 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $611,146 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 3,766 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 26.29% during the quarter. The current value of the position is $575,476 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,756 990 26.29 727 39.88 0.2595
2026-01-29 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,766 0 0.00 519 7.68 0.1528
2025-10-08 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,766 59 1.59 483 7.59 0.1540
2025-07-09 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,707 61 1.67 449 10.34 0.1535
2025-04-10 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,646 -182 -4.75 406 9.14 0.1574
2025-01-17 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,828 -132 -3.33 373 -18.24 0.1344
2024-10-18 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,960 716 22.07 455 31.88 0.1726
2024-07-22 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,244 -224 -6.46 345 2.99 0.1438
2024-04-19 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,468 51 1.49 335 -2.90 0.1303
2024-01-22 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,417 8 0.23 345 -0.58 0.1382
2023-10-25 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,409 6 0.18 347 1.17 0.1611
2023-07-20 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,403 -1 -0.03 343 9.58 0.1457
2023-04-06 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,404 -18 -0.53 313 0.97 0.1445
2023-01-17 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,422 -1 -0.03 310 19.23 0.1488
2022-10-17 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,423 -117 -3.31 260 -13.04 0.1417
2022-07-18 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,540 -25 -0.70 299 -4.47 0.1591
2022-04-18 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,565 104 3.00 313 3.30 0.1300
2022-01-31 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,461 15 0.44 303 7.45 0.1216
2021-10-13 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,446 19 0.55 282 -9.90 0.1209
2021-08-24 2021-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 3,427 -169 -4.70 313 1.95 0.0726
2021-07-22 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,427 -169 313 0.1271
2021-09-10 2021-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 3,596 42 1.18 307 -8.63 0.1404
2021-04-12 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,596 42 307 0.1225
2021-09-10 2020-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 3,554 -518 -12.72 336 -5.08 0.1744
2021-01-25 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,554 -518 336 0.1627
2021-09-10 2020-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 4,072 -161 -3.80 354 -4.32 0.1987
2020-10-21 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 4,072 -161 354 0.1872
2021-09-10 2020-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 4,233 -4,924 -53.77 370 -50.99 0.2135
2020-07-13 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,233 -4,924 370 0.2012
2020-05-07 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 9,157 -340 -3.58 755 -16.02 0.2181
2020-05-07 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 9,497 9,497 899 0.2324
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.